ClinicalTrials.govpublic full text
PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide
prostate cancer metastatic, castration-resistant prostate cancer, enzalutamide, imaging, pet/ct, whole body mri, circulating tumour cells, cell-free tumour dna, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 982710
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.